Advancements in drug delivery systems, such as oral GLP-1 agonists and once-weekly injections, aim to improve patient adherence and convenience, enhancing the overall management of chronic conditions like diabetes and obesity
There is no approved medication for it, and treatment mostly involves compression therapy
The GLP-1 Revolution: More Than Just Weight Loss GLP-1 (Glucagon-Like Peptide-1) receptor agonists, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), have gained attention for their remarkable weight loss effects
Science 354 , 572577 (2016)
With mature peptide synthesis and vacuum freeze-drying technology, we implement strict quality inspection for every batch and supply COA certificates
Kafri emphasizes that medications alone are not a magic fix for obesity